Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


11.05.2025

2 Acta Haematol
1 Am J Hematol
3 Ann Hematol
6 Blood
1 Cancer
1 Eur J Haematol
1 Exp Hematol
1 J Pediatr Hematol Oncol
1 Leuk Lymphoma
4 Leukemia
1 Oncogene
4 PLoS One
1 Semin Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. MCCALL D, Catueno S, Ramakrishnan R, Tewari P, et al
    Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia.
    Acta Haematol. 2025 May 5:1-31. doi: 10.1159/000546249.
    PubMed         Abstract available

  2. LE COUTRE P, Burchert A, Saussele S, Schwarzer T, et al
    Favorable rates of cardiovascular events with stringent cardiovascular monitoring and a lowered dose of ponatinib as second line treatment in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generatio
    Acta Haematol. 2025 May 5:1-13. doi: 10.1159/000545826.
    PubMed         Abstract available


    Am J Hematol

  3. CHALANDON Y, Devillier R, Boumendil A, Nguyen S, et al
    Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Societe Francophone de Greffe de Moelle et Therapie Cellulaire (SFGM-TC).
    Am J Hematol. 2025 May 6. doi: 10.1002/ajh.27701.
    PubMed         Abstract available


    Ann Hematol

  4. AVAL OS, Ahmadi A, Hemid Al-Athari AJ, Soleimani Samarkhazan H, et al
    "Galectin-9: A double-edged sword in Acute Myeloid Leukemia".
    Ann Hematol. 2025 May 9. doi: 10.1007/s00277-025-06387.
    PubMed         Abstract available

  5. PATRA PC, Rainchwar S, Singh R, Bhatia N, et al
    Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India.
    Ann Hematol. 2025;104:2483-2493.
    PubMed         Abstract available

  6. FUJI S, Tokunaga M, Utsunomiya A, Makiyama J, et al
    Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groups.
    Ann Hematol. 2025;104:2429-2436.
    PubMed         Abstract available


    Blood

  7. HOURIGAN CS
    From prognostication to precision in acute myeloid leukemia.
    Blood. 2025;145:2105-2106.
    PubMed        


  8. Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia. Blood. 2025;145(6):577-589.
    Blood. 2025;145:2231.
    PubMed        

  9. TEFFERI A, Fathima S, Abdelmagid M, Alsugair A, et al
    BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia.
    Blood. 2025 May 7:blood.2024027170. doi: 10.1182/blood.2024027170.
    PubMed         Abstract available

  10. ARELLANO ML, Thirman MJ, DiPersio JF, Heiblig M, et al
    Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.
    Blood. 2025 May 7:blood.2025028357. doi: 10.1182/blood.2025028357.
    PubMed         Abstract available

  11. LEVIS MJ, Hamadani M, Logan BR, Jones RJ, et al
    Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.
    Blood. 2025;145:2138-2148.
    PubMed         Abstract available

  12. GOOPTU M, Murdock HM, Soiffer RJ
    How I treat AML relapse after allogeneic HSCT.
    Blood. 2025;145:2128-2137.
    PubMed         Abstract available


    Cancer

  13. KANTARJIAN H, Jain N, Litzow MR, Luger SM, et al
    The evolving therapeutic revolution in adult acute lymphoblastic leukemia.
    Cancer. 2025;131:e35872.
    PubMed         Abstract available


    Eur J Haematol

  14. TADMOR T, Melamed G, Alapi H, Rokach L, et al
    CLLAF SCORE-A New Risk Score for Predicting Atrial Fibrillation in Treatment-Naive CLL Patients Initiating First- and Second-Generation BTK Inhibitor Therapy.
    Eur J Haematol. 2025;114:1011-1019.
    PubMed         Abstract available


    Exp Hematol

  15. CISA-WIECZOREK S, Hernandez-Alvarez MI, Parreno M, Munoz JP, et al
    D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1.
    Exp Hematol. 2025;145:104748.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  16. KURTIPEK FB, Kacar D, Dinc B, Ozkaya Parlakay A, et al
    Agrobacterium radiobacter-induced Port Catheter Bacteremia in a Pediatric Acute Lymphoblastic Leukemia Patient: A Rare Clinical Case.
    J Pediatr Hematol Oncol. 2025 May 5. doi: 10.1097/MPH.0000000000003045.
    PubMed        


    Leuk Lymphoma

  17. OTHMAN T, Lo MM, Andreadis CB, Damon LE, et al
    Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
    Leuk Lymphoma. 2025 May 7:1-4. doi: 10.1080/10428194.2025.2496333.
    PubMed        


    Leukemia

  18. IZUMI S, Ohtani K, Matsumoto M, Shibata S, et al
    Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia.
    Leukemia. 2025 May 8. doi: 10.1038/s41375-025-02638.
    PubMed         Abstract available

  19. NGUYEN LXT, Zhang B, Hoang DH, Zhao D, et al
    Correction: Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.
    Leukemia. 2025 May 5. doi: 10.1038/s41375-025-02637.
    PubMed        

  20. LAUSEKER M, Hoffmann VS, Pfirrmann M
    Prognostic scoring systems in chronic myeloid leukaemia.
    Leukemia. 2025;39:1046-1052.
    PubMed         Abstract available

  21. TAKAMORI H, Huang YJ, Fukushima H, Yokoyama K, et al
    Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation.
    Leukemia. 2025;39:1218-1227.
    PubMed         Abstract available


    Oncogene

  22. YAO L, Zhang X, Li X, Xu J, et al
    circAFF2 promotes the development of AML by binding to PML mRNA.
    Oncogene. 2025;44:1234-1244.
    PubMed         Abstract available


    PLoS One

  23. JAN Z, Shabir M, Farman H, Rahman A, et al
    Deep learning based semantic segmentation of leukemia effected white blood cell.
    PLoS One. 2025;20:e0320596.
    PubMed         Abstract available

  24. PARK H, Miyano S
    Network-based multi-class classifier to identify optimized gene networks for acute leukemia cell line classification.
    PLoS One. 2025;20:e0321549.
    PubMed         Abstract available

  25. HOLOUBEK A, Strachotova D, Wolfova K, Otevrelova P, et al
    Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.
    PLoS One. 2025;20:e0322096.
    PubMed         Abstract available

  26. WANG Z, Wang C, Zhang D, Wang X, et al
    The up-regulation of TGF-beta1 by miRNA-132-3p/WT1 is involved in inducing leukemia cells to differentiate into macrophages.
    PLoS One. 2025;20:e0306150.
    PubMed         Abstract available


    Semin Oncol

  27. ANGELO AA, Adane G, Berta DM, Elias Chane, et al
    The dual effect of interferon-gamma in acute myeloid leukemia: A narrative review.
    Semin Oncol. 2025;52:152347.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.